Evidence map›Paper›PMID 30824487›Full record

ArticleCancer discovery2019

Metabolism Drives Carcinogenesis and Maintenance of Pancreatic Tumors.

Christopher J Halbrook, Barbara S Nelson, Costas A Lysstiotis

Abstract readComment
PubMed Publisher
In one paragraph

Article in Cancer discovery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher J HalbrookDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.
Barbara S NelsonDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan.ORCID 0000-0001-9316-4482
Costas A LysstiotisDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, Michigan. clyssiot@med.umich.edu.ORCID 0000-0001-9309-6141
University of Michigan · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
Training in Basic and Translational Digestive SciencesT32DK094775 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI JOHN Y KAO, LINDA C. SAMUELSON · 2012 to 2026
$3.6M
Targeting Epithelial-Immune Cell Crosstalk to Improve Therapy in Pancreatic CancerF32CA228328 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HALBROOK, CHRISTOPHER J. · 2018 to 2019
$117k
NCATS NIH HHS UL1 TR000433NCI NIH HHS F32 CA228328NCI NIH HHS P30 CA046592NIDDK NIH HHS T32 DK094775
6 · The paper itself

Abstract

In this issue of

Indexed as

Pancreatic NeoplasmsAcetyl Coenzyme ACarcinogenesisDriveHumansMaintenanceAcetyl Coenzyme A

Identifiers

PMID30824487
OpenAlexW2918835953

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.